quinazolines has been researched along with Neoplasms, Bronchial in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, JH; Li, MF; Shiau, EL; Wu, MT | 1 |
| Balázs, G; Kovalszky, I; Losonczy, G; Moldvay, J; Pápay, J; Puskás, R | 1 |
| Blandin, S; Gérinière, L; Girard, N; Perrot, E; Souquet, PJ | 1 |
| Gaya, A; Khorshid, M; Plowman, PN; Walther, JC | 1 |
| Zalcman, G | 1 |
| Pérol, M | 1 |
| Bréchot, JM | 1 |
| Quoix, E | 1 |
| Soria, JC | 1 |
| Hegab, AE; Homma, S; Iizuka, T; Ishii, Y; Kiwamoto, T; Matsuno, Y; Morishima, Y; Nomura, A; Sakamoto, T; Sekizawa, K | 1 |
10 other study(ies) available for quinazolines and Neoplasms, Bronchial
| Article | Year |
|---|---|
Recurrent respiratory papillomatosis with lung involvement and malignant transformation.
Topics: Bronchial Neoplasms; Bronchoscopy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chemoradiotherapy, Adjuvant; Contrast Media; Disease Progression; Erlotinib Hydrochloride; Humans; Male; Middle Aged; Papillomavirus Infections; Protein Kinase Inhibitors; Quinazolines; Respiratory Tract Infections; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Disease Progression; Docetaxel; ErbB Receptors; Exons; Female; Gefitinib; Gene Deletion; Genes, erbB-1; Humans; Molecular Targeted Therapy; Quinazolines; Remission Induction; Retreatment; Taxoids; Treatment Outcome | 2014 |
[French experience of gefitinib in non-small cell bronchial carcinoma].
Topics: Adult; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Epidermal Growth Factor; Female; Gefitinib; Humans; Male; Middle Aged; Palliative Care; Protein-Tyrosine Kinases; Quinazolines; Retrospective Studies; Sex Factors; Smoking | 2004 |
Cross-over response to erlotinib of brain metastatic disease from bronchial adenocarcinoma after gefitinib failure, and an unusual rash.
Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Bronchial Neoplasms; Drug Hypersensitivity; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Middle Aged; Quinazolines; Skin Diseases, Vesiculobullous | 2006 |
[EGFR pathway and mechanism of action of tyrosine kinase inhibitors].
Topics: Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Chromosomes, Human, Pair 7; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Genes, erbB-2; Genes, ras; Humans; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Respiratory Mucosa | 2007 |
[Clinical results observed with tyrosine kinase inhibitors].
Topics: Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome | 2007 |
[Associations of tyrosine kinase inhibitors with chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Erlotinib Hydrochloride; Gefitinib; Humans; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome | 2007 |
[Use of tyrosine kinase inhibitors in particular situations].
Topics: Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome | 2007 |
[Perspectives and future developments of epidermal growth factor receptors inhibitors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Therapy, Combination; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome | 2007 |
Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Bronchi; Bronchial Neoplasms; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Chloride Channels; ErbB Receptors; Gene Expression; Humans; Male; Mucin 5AC; Mucins; Niflumic Acid; Protein Tyrosine Phosphatases; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Smoking; Tyrphostins | 2007 |